Medicare Advantage and Prescription Drug Program: Final Marketing Provisions in 42 CFR 422.111(h)(1)(iii) and 423.128(d)(1)(iii) (CMS-10802)

ICR 202201-0938-007

OMB: 0938-1421

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2022-01-12
IC Document Collections
ICR Details
202201-0938-007
Received in OIRA
HHS/CMS CM-CPC
Medicare Advantage and Prescription Drug Program: Final Marketing Provisions in 42 CFR 422.111(h)(1)(iii) and 423.128(d)(1)(iii) (CMS-10802)
New collection (Request for a new OMB Control Number)   No
Regular 01/13/2022
  Requested Previously Approved
36 Months From Approved
20,800,000 0
0 0
312,000 0

CMS requires MA organizations and Part D sponsors to use the standardized document being submitted for OMB approval to satisfy disclosure requirements mandated by section 1851 (d)(3)(A) of the Act and 42 CFR 422.111 for MA organizations and section 1860D-1(c) of the Act and 42 CFR 423.128(a)(3) for Part D sponsors. We are proposing to reinstitute a requirement to use the MLI under §§ 422.2267(e)(31) and 423.2267(e)(33).

US Code: 42 USC 1851(d)(3)(A) and 1860D-1(c) Name of Law: Social Security Act
  
None

0938-AU30 Proposed rulemaking 87 FR 1842 01/12/2022

  87 FR 1842 01/12/2022
No

1
IC Title Form No. Form Name
Multi-Language Insert

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 20,800,000 0 0 20,800,000 0 0
Annual Time Burden (Hours) 0 0 0 0 0 0
Annual Cost Burden (Dollars) 312,000 0 0 312,000 0 0
No
No

$7,646
No
    No
    No
No
No
No
No
Mitch Bryman 410 786-5258 Mitch.Bryman@cms.hhs.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
01/13/2022


© 2024 OMB.report | Privacy Policy